Murali Doraiswamy, M.D.

Dr. Murali Doraiswamy is a Professor of Translational Neuroscience as well as Director of the Neurocognitive Disorders Program in the Department of Psychiatry at Duke University Medical Center. He also serves on the Executive Committee of the Duke Institute for Brain Sciences and as a Senior Fellow at the Duke Center for the Study of Aging. Dr. Doraiswamy directs a leading clinical trials unit which has been involved in the development of many of the leading products used today to treat cognitive and neuropsychiatric conditions. He is also widely recognized for his work in the study of imaging biomarkers (such as MRI volumetrics, amyloid PET and functional MRI). Dr. Doraiswamy is a Fellow of the Royal College of Physicians (London), a Fellow of the American Neurological Association and a member of the World Economic Forum’s Global Agenda Council on Brain Research. He also serves as an advisor to leading government agencies, biotech and health companies, and patient advocacy groups. Dr. Doraiswamy is a brain health advisor for Men’s Health magazine and serves as an Alzheimer’s advisor for AARP. He is co-author of a popular book, The Alzheimer’s Action Plan.

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Pathway Cross-talks Associated with Sex and Risk for Alzheimer’s Disease 2016 to 2017

$303,931

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Kanchana Padmanabhan, Katie Shpanskaya, Gonzalo Bello, P. Murali Doraiswamy, Nagiza F. Samatova Toward Personalized Network Biomarkers in Alzheimer’s Disease: Computing Individualized Genomic and Protein Crosstalk Maps, Frontiers in Aging Neuroscience, 26 Sep 2017, Read More

Kanchana Padmanabhan, Kelly Nudelman, Steve Harenberg, Gonzalo Bello, Dongwha Sohn, Katie Shpanskaya, Priyanka Tiwari Dikshit, Pallavi S. Yerramsetty, Rudolph E. Tanzi, Andrew J. Saykin, Jeffrey R. Petrella, P. Murali Doraiswamy, Nagiza F. Samatova, Alzheimer’s Disease Neuroimaging Initiative Characterizing Gene and Protein Crosstalks in Subjects at Risk of Developing Alzheimer’s Disease: A New Computational Approach, Processes, 5(3), Sep 2017, 47, Read More

Dragan Gamberger, Nada Lavrač, Shantanu Srivatsa, Rudolph E. Tanzi, P. Murali Doraiswamy Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease, Scientific Reports, 7, 28 Jul 2017, Read More

Joshua G Hunsberger, PhD, Mahendra Rao, MD, Joanne Kurtzberg, MD, Jeff W M Bulte, PhD, Anthony Atala, MD, Frank M LaFerla, PhD, Henry T Greely, JD, Akira Sawa,MD, Sam Gandy, MD, Lon S Schneider, MD, P Murali Doraiswamy, MBBS Accelerating stem cell trials for Alzheimer’s disease, The Lancet Neurology, 15(2), February 2016, 219–230, Read More